Phase II study of the anti-ganglioside GD3 mouse/human chimeric antibody KW2871 combined with high dose interferon-a2b in patients with metastatic melanoma von Moschos, Stergios J., Tarhini, Ahmad A., Gajewski, Thomas, Scott, Andrew Mark, Lin, Yan, Shipe-Spotloe, Janice, Deblasio, Weiping Xu, Sander, Cindy, Matijevich, Karen, Smyth, Fiona Elizabeth, Liu, Zhanqi, Hoffman, Eric W., Venhaus, Ralph Rudolph, Pan, Linda S., Tran, Sinhan, Fiore, James, Kirkwood, John M.

Volltext